Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jan Eckermann

Neurological Surgery Bakersfield, CA Medical Doctor

NPI 1962619668 CMS profile 362309

1700 Mt. Vernon Ave., Room 2562-B, Bakersfield, CA 93306

Open in the dashboard

General payments

$66,196

739 records reported · program years 2019–2025

Research payments

$15,000

Paid to them · 5 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$11,700 paid to institutions, not to them · program year 2020

Through program year 2025, Jan Eckermann of Bakersfield, CA is reported in the CMS Open Payments database as having received $66,196 across 739 general payments and $15,000 in research payments paid to them. Separately, studies naming them as principal investigator received $11,700 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 89th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,424 78
2024 General $3,147 71
2023 General $4,663 104
2022 General $3,029 90
2022 Research $1,500 1
2021 General $8,543 122
2021 Research $13,500 4
2020 General $4,060 127
2019 General $39,330 147

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jan Eckermann
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Jan Eckermann were reported at $3,424. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Jan Eckermann Neurological Surgery median Middle half National median
2019 $39,330 $582 $138–$3,006 $163
2020 $4,060 $294 $76–$2,174 $114
2021 $8,543 $387 $105–$2,432 $132
2022 $3,029 $542 $139–$2,989 $149
2023 $4,663 $534 $145–$2,697 $160
2024 $3,147 $574 $155–$3,046 $164
2025 $3,424 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Nevro Corp. $29,700 203 payments
  2. Medtronic, Inc. $16,809 335 payments
  3. Boston Scientific Corporation $14,852 104 payments
  4. Abbott Laboratories $2,786 58 payments
  5. Globus Medical, Inc. $882 20 payments
  6. Saluda Medical Americas, Inc. $529 5 payments
  7. Nalu Medical, Inc. $182 3 payments
  8. Medtronic USA, Inc. $164 6 payments
  9. SI-BONE, Inc. $143 1 payment
  10. Smith+Nephew, Inc. $47 1 payment
  11. Other $102 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $34,875 10 payments
  2. Food and Beverage $28,467 721 payments
  3. Travel and Lodging $2,854 8 payments
Products named General payments · program years 2019–2025
  1. Senza Spinal Cord Stimulation System $27,006 160 payments
  2. INTELLIS ADAPTIVESTIM $9,934 231 payments
  3. PRECISION $9,625 3 payments
  4. General Therapies $2,855 7 payments
  5. Omnia $2,503 36 payments
  6. Proclaim Family of SCS IPGs $1,853 41 payments
  7. INTELLIS $1,789 36 payments
  8. INCEPTIV $1,508 38 payments
  9. Senza $882 20 payments
  10. GENERAL PAIN MANAGEMENT $826 28 payments
  11. Other $3,987 115 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Nevro Corp. $15,000 5 payments

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

42

Median for Neurosurgery: 83

Drug cost

$305

Median for Neurosurgery: $872

Branded share of claims

57.1%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Cephalexin Generic 18 $164
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 11 $100
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 13 $41

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 9 billing codes

Paid by Medicare

$8,461

Medicare's payments for the services billed

Medicare patients

42

Average age 70

Services billed

60

25 women, 17 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 50%
Ischemic heart disease 31%
Depression 29%
Chronic kidney disease 26%
COPD 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

744 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record